15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Argan Inc, 3 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $369.00 to $600.00, a moderate spread. The average target of $481.17 sits 10% above the current $437.22. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 33% this year and 21% next, consensus EPS building from about $2.99 next quarter toward $15.76 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy350%
Hold350%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Argan Inc.
As of Sep, 3 of 6 firms rate AGX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AGX EPS & revenue forecast
EPS · NEXT QUARTER
$2.99
Range $2.84 – $3.12 · 3 analysts · +38% YoY
Next period, 3 analysts expect Argan Inc to earn $2.99 a share (range $2.84 – $3.12), versus $2.17 a year earlier. Full-year consensus is $12.74, growing to $15.76 the year after.
REVENUE · NEXT QUARTER
$366.7M
Range $340.0M – $402.0M · 3 analysts · +25% YoY
Revenue is expected to reach $366.7M (range $340.0M – $402.0M), +25.0% year-over-year. Full-year consensus is $1.4B, rising to $1.7B next year.
Top analysts covering Argan Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AGX.
#1
RB
Robert Brown
Lake Street
Hold
$600.00+37.2% to target
Coverage
—
+ Follow
#2
MF
Michael Fairbanks
JP Morgan
Buy
$800.00+83.0% to target
Coverage
—
+ Follow
#3
AW
Austin Wang
GLJ Research
Buy
$369.00-15.6% to target
Coverage
—
+ Follow
#4
AM
Atidrip Modak
Goldman Sachs
Buy
$518.00+18.5% to target
Coverage
—
+ Follow
#5
SG
Sergey Glinyanov
Freedom Broker
Hold
$425.00-2.8% to target
Coverage
—
+ Follow
AGX stock forecast FAQ
What is AGX's average 12-month price target?+
The 5 analysts with a live target average $481.17 for Argan Inc over the next 12 months, ranging from a $600.00 high to a $369.00 low.
Is AGX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 3 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AGX?+
The Street-high target is $600.00 (Lake Street), and the Street-low is $369.00 (GLJ Research). The average of all 5 active targets is $481.17.
How many Wall Street analysts cover AGX?+
6 analysts have an active rating on Argan Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering AGX?+
Among analysts who currently cover AGX, Robert Brown of Lake Street has the strongest overall Quantellect track record. Their current call is Hold with a $600.00 target.
What is Argan Inc's projected EPS for next quarter?+
The consensus estimate is $2.99 per share (range $2.84 – $3.12) across 3 analysts. Full-year EPS is projected at $12.74, rising to $15.76 the following year.
How much revenue is Argan Inc expected to report next quarter?+
Consensus revenue is $366.7M (range $340.0M – $402.0M). Full-year revenue is projected at $1.4B, growing to $1.7B next year.
Have analysts been upgrading or downgrading AGX lately?+
As of Sep, 3 of 6 firms rate AGX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AGX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
